Stocks Industrials NXTS
NASDAQ · IndustrialsNexentis Technologies Inc. (NXTS)
It posted a net loss of $16M. In fiscal 2025 capital spending exceeded operating cash flow by $3.8M. At June 30, 2026 it held $7.6M in cash. Its latest periodic report to the SEC is the quarterly report (10-Q) filed on August 13, 2026.
Watch NXTS in 60 secondsWhat Nexentis Technologies Inc. does
Nexentis Technologies Inc. is registered with the SEC under industry code SIC 2834 (Pharmaceutical Preparations). Its shares trade on NASDAQ under the ticker NXTS.
Revenue and profit by year
Key figures
| Fiscal year | Revenue | Net income | Diluted EPS | Free cash flow |
|---|---|---|---|---|
| 2025 | n/a | -$4M | -$8.61 | -$3.8M |
| 2024 | $210K | -$5.2M | -$27.74 | n/a |
| 2023 | $263.4K | -$6.5M | -$169.25 | n/a |
| 2022 | $394K | -$5.7M | $338.18 | -$5.1M |
| 2021 | $438.1K | -$4.8M | -$64.21 | -$4.2M |
| 2020 | $232.3K | -$1.6M | -$32.73 | n/a |
Full financial statements: income, balance sheet and cash flow
Latest SEC filings
What Nexentis Technologies Inc. has filed recently, newest first. Each links to the original document on SEC EDGAR.
- September 3, 2026
- August 13, 2026
- August 6, 2026Auditor change 8-K
- July 15, 2026Passive stake changed SCHEDULE 13G/A
- July 13, 2026IPO registration S-1
- July 13, 2026Form POS AM filing POS AM
- June 23, 2026
- June 22, 2026
- June 15, 2026
- June 12, 2026
Insider trades
What the people running Nexentis Technologies Inc. did with its shares, from the Form 4 filings they must send the SEC within two business days.
No insider trades were reported in the last 90 days.
| Date | Insider | What | Shares | Value |
|---|---|---|---|---|
| February 9, 2026 | Barda LitalChief Financial Officer | Received as payindirect | 50,000 | - |
| February 9, 2026 | Weiss AmitayDirector | Received as payindirect | 116,286 | - |
| February 9, 2026 | Palach DavidChief Executive Officer | Received as payindirect | 100,000 | - |
| February 9, 2026 | Zakai ShlomoController | Received as payindirect | 50,000 | - |
| January 29, 2026 | Lee Eun Young10% owner | Sold | 127 | $172.1 |
Who owns NXTS
Three views from three kinds of SEC filings, each with its own date. They overlap and are not added up.
5% holders
| Holder | Of class | Filed |
|---|---|---|
| SciSparc Ltd.13G, passive | 18.3% | October 24, 2025 |
| Alon Silberman13G, passive | 16.93% | October 28, 2025 |
Largest institutional holders
Insiders
5 insiders reported holding 866,960 shares in total, about $1.3M at the last price.
| Holder | Shares |
|---|---|
| Lee Eun Young10% owner | 479,524 |
| Weiss AmitayDirector | 129,144129,144 held indirectly |
| Palach DavidChief Executive Officer | 129,144129,144 held indirectly |
| Zakai ShlomoController | 64,77864,778 held indirectly |
| Barda LitalChief Financial Officer | 64,37064,370 held indirectly |
Questions about NXTS
What does Nexentis Technologies Inc. do?
Nexentis Technologies Inc. is registered with the SEC under industry code SIC 2834 (Pharmaceutical Preparations). Its shares trade on NASDAQ under the ticker NXTS.
Is Nexentis Technologies Inc. profitable?
No. Over the twelve months to June 30, 2026 it reported a net loss of $16M.
When did Nexentis Technologies Inc. last report?
Its most recent periodic report is the quarterly report (10-Q) filed on August 13, 2026. It covers the period to June 30, 2026. Its newest filing of any kind is the stock exchange listing notice from September 3, 2026.
Similar companies
Compare NXTS with
Follow NXTS
Get an email when Nexentis Technologies Inc. files with the SEC: results, executive changes, material agreements and annual reports.
Follow NXTS: get an email when it filesWhere the numbers come from
Financial figures are the values Nexentis Technologies Inc. tagged in its own SEC filings (XBRL), taken from the latest filing for each period, so restatements replace older figures. Revenue, profit and cash flow are for full fiscal years unless marked as the last twelve months, which is the sum of the four most recent quarters. Where a company reports only the full year, the fourth quarter is the year minus the first three.
Prices are delayed end-of-day market data in the listing currency, and market cap moves with the price. P/E is shown only when earnings per share are positive. Nothing here is investment advice.